When Wall Street sees fit to raise the grade on a company's stock, there's generally a rush from the momentum investing crowd to pile in. And if quarterly estimates are exceeded for the stock, you can usually count on a further buying surge from that same cohort. In short, the standards and expectations that Wall Street investment houses set for the companies they cover may be a moving target, ever adjusted and readjusted as new data become available. But when either the bar is raised or reported results are bested, the money flows rise.
IN PICTURES: 9 Ways To Use A Tax Refund

Here are three stocks that recently saw at least one major brokerage elevate them to a higher investment rung.

Cleanest Stock In The Land

The Clorox Co. (NYSE: CLX) manufactures a wide variety of consumer products including bleaches and other household cleaning products, STP and Armor All auto care products and Brita water filtration systems. Barclays recently upgraded Clorox from "Equal Weight" to "Overweight" and raised the company's share price target from $67 to $71.

Clorox shares are up better than 26% in the last year and trade with a price/earnings (P/E) ratio of 15.36. The share yield is an annual 3.13% and is up 13.25% over last year's payout. Earnings per share (EPS) growth for the last five years is an impressive 10.74%.

Anti-Cancer Therapeutics

Onyx Pharmaceuticals (Nasdaq: ONXX) along with its partner, drug giant Bayer AG (OTC: BAYRY), is in the business of developing and commercializing therapies for kidney and liver cancer, among others. Goldman Sachs just upped the ante on Onyx, lifting the company from a "Neutral" rating to a "Buy".

Onyx shares have risen 10% in the last year, trailing the Pharmaceutical HOLDRs ETF (NYSE: PPH), which rose nearly 19%, but Goldman believes the company is now a ripe takeover target.

Starbucks Bucks

Starbucks (Nasdaq: SBUX) may already be everyone's favorite coffee destination, but it's now also been fingered by UBS for an upgrade from "Neutral" to "Buy".

Starbucks stock rose nearly 115% in the last 12 months, better than doubling the performance of the broad Nasdaq index, represented by the PowerShares QQQ Trust ETF (Nasdaq: QQQQ).

The Wrap

Analyst upgrades are gravy on the momentum investor's meat and potatoes. Look for more upside action on these stocks in the weeks and months ahead. (For more on analyst expectations, be sure to read Analyst Recommendations: Do Sell Ratings Exist?)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

Related Articles
  1. Chart Advisor

    Watch This ETF For Signs Of A Reversal (BCX)

    Trying to determine if the commodity markets are ready for a bounce? Take a look at the analysis of this ETF to find out if now is the time to buy.
  2. Investing News

    What You Can Learn from Carl Icahn's Mistakes

    Carl Icahn has been a stellar performer in the investment world for decades, but following his lead these days could be dangerous.
  3. Mutual Funds & ETFs

    ETFs Can Be Safe Investments, If Used Correctly

    Learn about how ETFs can be a safe investment option if you know which funds to choose, including the basics of both indexed and leveraged ETFs.
  4. Mutual Funds & ETFs

    The Top 5 Large Cap Core ETFs for 2016 (VUG, SPLV)

    Look out for these five ETFs in 2016, and learn why investors should closely watch how the Federal Reserve moves heading into the new year.
  5. Economics

    India: Why it Might Pay to Be Bullish Right Now

    Many investors are bullish on India for all the right reasons. Does it present an investing opportunity?
  6. Stock Analysis

    Analyzing Altria's Return on Equity (ROE) (MO)

    Learn about Altria Group's return on equity (ROE) and analyze net profit margin, asset turnover and financial leverage to determine what is causing its high ROE.
  7. Investing Basics

    Building My Portfolio with BlackRock ETFs and Mutual Funds (ITOT, IXUS)

    Find out how to construct the ideal investment portfolio utilizing BlackRock's tools, resources and its popular low-cost exchange-traded funds (ETFs).
  8. Investing News

    Icahn's Bet on Cheniere Energy: Should You Follow?

    Investing legend Carl Icahn continues to lose money on Cheniere Energy, but he's increasing his stake. Should you follow his lead?
  9. Stock Analysis

    Analyzing Google's Return on Equity (ROE) (GOOGL)

    Learn about Alphabet's return on equity. How has its ROE changed over time, how does it compare to its peers and what factors are driving ROE for the company?
  10. Investing News

    Is Buffett's Bet on Oil Right for You? (XOM, PSX)

    Oil stocks are getting trounced, but Warren Buffett still likes one of them. Should you follow the leader?
RELATED FAQS
  1. Should mutual funds be subject to more regulation?

    Mutual funds, when compared to other types of pooled investments such as hedge funds, have very strict regulations. In fact, ... Read Full Answer >>
  2. Do ETFs pay capital gains?

    Exchange-traded funds (ETFs) can generate capital gains that are transferred to shareholders, typically once a year, triggering ... Read Full Answer >>
  3. How do real estate hedge funds work?

    A hedge fund is a type of investment vehicle and business structure that aggregates capital from multiple investors and invests ... Read Full Answer >>
  4. Are Vanguard ETFs commission-free?

    While some Vanguard exchange-traded funds (ETFs) are available commission-free from third-party brokers, a large portion ... Read Full Answer >>
  5. Do Vanguard ETFs require a minimum investment?

    Vanguard completely waives any U.S. dollar minimum amounts to buy its exchange-traded funds (ETFs), and the minimum ETF investment ... Read Full Answer >>
  6. Can mutual fund expense ratios be negative?

    Mutual fund expense ratios cannot be negative. An expense ratio is the sum total of all fees charged by an asset management ... Read Full Answer >>
COMPANIES IN THIS ARTICLE
Trading Center